Impact of myocardial bridge on lesion morphology and clinical outcomes in patients undergoing IVUS-guided PCI for LAD CTO
Frontiers in Cardiovascular Medicine · 21.07.2025 · 12
DOI: 10.3389/fcvm.2025.1648233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.07.2025. Verfasst von Xi Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, Hunan, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Myocardial bridge (MB) is increasingly recognized for its potential role in coronary artery disease. However, its impact on lesion morphology and clinical outcomes in patients with left anterior descending (LAD) chronic total occlusion (CTO) undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) remains unclear.
Methods
This single-center retrospective study analyzed 256 patients who underwent IVUS-guided PCI for LAD CTO between 2016 and 2022. Patients were divided into MB ( n = 61) and non-MB ( n = 195) groups based on IVUS findings. Lesion characteristics, stent strategy, and 2-year clinical outcomes were compared.
Results
MB was identified in 23.8% of patients. Compared with the non-MB group, MB patients had significantly shorter CTO length (17.71 mm vs. 21.31 mm, P < 0.001), less calcification (29.5% vs. 47.7%, P = 0.018), and more proximal lesion distribution (41.0% vs. 20.0%, P = 0.001). Despite these favorable anatomical features, the MB group had higher rates of major adverse cardiovascular events (MACE) (19.7% vs. 8.7%, P = 0.033) and clinically driven target lesion revascularization (18.0% vs. 6.7%, P = 0.016). MB was an independent predictor of MACE (HR = 2.173, P = 0.021).
Discussion
MB is associated with distinct morphological features and worse clinical outcomes in LAD CTO patients undergoing PCI. Its presence may require careful procedural planning and personalized revascularization strategies to reduce long-term risks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, Hunan, China.
Zitieren
APA
Wu, X., Wu, M., Huang, H., Liu, Z., Huang, H., & Wang, L. (2025). Impact of myocardial bridge on lesion morphology and clinical outcomes in patients undergoing IVUS-guided PCI for LAD CTO. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1648233
Vancouver
Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L. Impact of myocardial bridge on lesion morphology and clinical outcomes in patients undergoing IVUS-guided PCI for LAD CTO. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1648233
BibTeX
@article{Wu2025,
author = {Wu, Xi and Wu, Mingxing and Huang, Haobo and Liu, Zhe and Huang, He and Wang, Lei},
title = {Impact of myocardial bridge on lesion morphology and clinical outcomes in patients undergoing IVUS-guided PCI for LAD CTO},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1648233}
}
EUVIMED